Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rylie’s Sunshine is a health and wellness company specializing in the development and distribution of high-quality, full-spectrum hemp-derived CBD products. Founded by Rylie Maedler, a young advocate who successfully used medical cannabis to treat a rare aggressive giant cell granuloma, the company focuses on providing therapeutic-grade oils and topicals for both pediatric and adult patients. Their product line is formulated with a focus on purity and efficacy, leveraging organic farming practices and proprietary extraction methods. The company operates alongside a non-profit foundation to advocate for medical cannabis research and access. Rylie’s Sunshine emphasizes transparency through rigorous third-party lab testing for all its formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rylie’s Sunshine.